Zhang J, Ji D, Cai L, Yao H, et al. First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study. Clin Cancer Res 2021 Nov 29. pii: 1078-0432.CCR-21-2827.
PMID: 34844975